| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 745.54B | 708.98B | 660.84B | 618.90B | 516.44B |
| Gross Profit | 252.61B | 227.80B | 219.01B | 195.64B | 171.02B |
| EBITDA | 106.26B | 104.19B | 97.42B | 81.02B | 72.30B |
| Net Income | 61.62B | 61.70B | 56.44B | 43.73B | 38.90B |
Balance Sheet | |||||
| Total Assets | 751.66B | 679.41B | 667.88B | 566.38B | 503.06B |
| Cash, Cash Equivalents and Short-Term Investments | 111.77B | 106.18B | 119.16B | 99.35B | 79.23B |
| Total Debt | 61.43B | 59.01B | 59.91B | 50.98B | 43.46B |
| Total Liabilities | 182.82B | 163.36B | 169.62B | 149.41B | 139.15B |
| Stockholders Equity | 560.92B | 508.54B | 491.36B | 410.51B | 357.82B |
Cash Flow | |||||
| Free Cash Flow | 34.12B | 35.71B | 51.10B | 33.60B | 33.40B |
| Operating Cash Flow | 90.51B | 75.20B | 80.81B | 59.20B | 52.09B |
| Investing Cash Flow | -43.24B | -39.67B | -42.99B | -26.62B | -16.11B |
| Financing Cash Flow | -53.09B | -46.09B | -31.42B | -20.38B | -17.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥118.26B | 6.86 | ― | 1.08% | 1.67% | -6.47% | |
71 Outperform | ¥1.39T | 21.75 | 11.19% | 1.46% | 5.16% | 1.57% | |
71 Outperform | ¥576.87B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
68 Neutral | ¥292.75B | 10.81 | 4.15% | 1.66% | 1.52% | -7.79% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥4.57T | 20.92 | 9.46% | 1.32% | 1.38% | -12.32% | |
61 Neutral | ¥221.75B | 30.94 | ― | 2.11% | -3.91% | -13.01% |